Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
Sign Up to like & getrecommendations! Published in 2020 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12649
Abstract: Centrifugal continuous flow pumps are currently the state of the art in left ventricular assist device therapy. This study was conducted to compare the results after implantation of the HVAD® and the HeartMate 3®. read more here.
Keywords: heartmate; term outcome; comparing short; hvad ... See more keywords